These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 22132117)

  • 1. Lithium monotherapy increases ACTH and cortisol response in the DEX/CRH test in unipolar depressed subjects. A study with 30 treatment-naive patients.
    Bschor T; Ritter D; Winkelmann P; Erbe S; Uhr M; Ising M; Lewitzka U
    PLoS One; 2011; 6(11):e27613. PubMed ID: 22132117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lithium augmentation increases the ACTH and cortisol response in the combined DEX/CRH test in unipolar major depression.
    Bschor T; Adli M; Baethge C; Eichmann U; Ising M; Uhr M; Modell S; Künzel H; Müller-Oerlinghausen B; Bauer M
    Neuropsychopharmacology; 2002 Sep; 27(3):470-8. PubMed ID: 12225704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between response to lithium augmentation and the combined DEX/CRH test in major depressive disorder.
    Bschor T; Baethge C; Adli M; Eichmann U; Ising M; Uhr M; Modell S; Künzel H; Müller-Oerlinghausen B; Bauer M
    J Psychiatr Res; 2003; 37(2):135-43. PubMed ID: 12842167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of citalopram on the HPA system. A study of the combined DEX/CRH test in 30 unipolar depressed patients.
    Bschor T; Ising M; Erbe S; Winkelmann P; Ritter D; Uhr M; Lewitzka U
    J Psychiatr Res; 2012 Jan; 46(1):111-7. PubMed ID: 22030468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined dexamethasone/corticotropin releasing hormone test predicts treatment response in major depression - a potential biomarker?
    Ising M; Horstmann S; Kloiber S; Lucae S; Binder EB; Kern N; Künzel HE; Pfennig A; Uhr M; Holsboer F
    Biol Psychiatry; 2007 Jul; 62(1):47-54. PubMed ID: 17123470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time course of hypothalamic-pituitary-adrenocortical axis activity during treatment with reboxetine and mirtazapine in depressed patients.
    Schüle C; Baghai TC; Eser D; Zwanzger P; Jordan M; Buechs R; Rupprecht R
    Psychopharmacology (Berl); 2006 Jul; 186(4):601-11. PubMed ID: 16758243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cortisol response in the combined dexamethasone/CRH test as predictor of relapse in patients with remitted depression. a prospective study.
    Zobel AW; Nickel T; Sonntag A; Uhr M; Holsboer F; Ising M
    J Psychiatr Res; 2001; 35(2):83-94. PubMed ID: 11377437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The combined dexamethasone/CRH Test (DEX/CRH test) and prediction of acute treatment response in major depression.
    Schüle C; Baghai TC; Eser D; Häfner S; Born C; Herrmann S; Rupprecht R
    PLoS One; 2009; 4(1):e4324. PubMed ID: 19177168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The dexamethasone/corticotropin-releasing hormone test in depression in bipolar and unipolar affective illness.
    Rybakowski JK; Twardowska K
    J Psychiatr Res; 1999; 33(5):363-70. PubMed ID: 10504004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined dexamethasone suppression-corticotrophin-releasing hormone stimulation test in medication-free major depression and healthy volunteers.
    Sher L; Oquendo MA; Burke AK; Cooper TB; Mann JJ
    J Affect Disord; 2013 Dec; 151(3):1108-12. PubMed ID: 23866302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cortisol response patterns in depressed women and their healthy daughters at risk: Comparison with healthy women and their daughters.
    Gonul AS; Cetinkalp S; Tunay S; Polat I; Simsek F; Aksoy B; Kizilates G; Erdogan Y; Coburn KL
    J Psychiatr Res; 2017 Feb; 85():66-74. PubMed ID: 27837659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sleep deprivation and hypothalamic-pituitary-adrenal (HPA) axis activity in depressed patients.
    Schüle C; Baghai T; Zwanzger P; Minov C; Padberg F; Rupprecht R
    J Psychiatr Res; 2001; 35(4):239-47. PubMed ID: 11578642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a salivary based combined dexamethasone/CRH test in patients with major depression.
    Baghai TC; Schüle C; Zwanzger P; Minov C; Holme C; Padberg F; Bidlingmaier M; Strasburger CJ; Rupprecht R
    Psychoneuroendocrinology; 2002 Apr; 27(3):385-99. PubMed ID: 11818173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lithium augmentation increases post-dexamethasone cortisol in the dexamethasone suppression test in unipolar major depression.
    Bschor T; Baethge C; Adli M; Eichmann U; Ising M; Uhr M; Müller-Oerlinghausen B; Bauer M
    Depress Anxiety; 2003; 17(1):43-8. PubMed ID: 12577277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissociation between ACTH and cortisol response in DEX-CRH test in patients with panic disorder.
    Petrowski K; Wintermann GB; Kirschbaum C; Bornstein SR
    Psychoneuroendocrinology; 2012 Aug; 37(8):1199-208. PubMed ID: 22277728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can the DEX/CRH test or markers of oxidative stress distinguish work-related stress from major depressive disorder and normal controls?
    Rotvig DH; Jorgensen A; Jensen JH; Hansen AR; Eller NH; Jonsson SH; Knorr U; Klose MC; Feldt-Rasmussen U; Menke A; Poulsen HE; Bauer JØ; Jørgensen MB
    Stress; 2024 Jan; 27(1):2353781. PubMed ID: 38823417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcome after lithium augmentation in unipolar depression: focus on HPA system activity.
    Adli M; Bschor T; Bauer M; Lucka C; Lewitzka U; Ising M; Uhr M; Mueller-Oerlinghausen B; Baethge C
    Neuropsychobiology; 2009; 60(1):23-30. PubMed ID: 19684420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term citalopram administration reduces responsiveness of HPA axis in patients with major depression: relationship with S-citalopram concentrations in plasma and cerebrospinal fluid (CSF) and clinical response.
    Nikisch G; Mathé AA; Czernik A; Thiele J; Bohner J; Eap CB; Agren H; Baumann P
    Psychopharmacology (Berl); 2005 Oct; 181(4):751-60. PubMed ID: 15988572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological and nonpharmacological factors influencing hypothalamic-pituitary-adrenocortical axis reactivity in acutely depressed psychiatric in-patients, measured by the Dex-CRH test.
    Künzel HE; Binder EB; Nickel T; Ising M; Fuchs B; Majer M; Pfennig A; Ernst G; Kern N; Schmid DA; Uhr M; Holsboer F; Modell S
    Neuropsychopharmacology; 2003 Dec; 28(12):2169-78. PubMed ID: 12931142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal neuroendocrine changes assessed by dexamethasone/CRH and growth hormone releasing hormone tests in psychotic depression.
    Owashi T; Otsubo T; Oshima A; Nakagome K; Higuchi T; Kamijima K
    Psychoneuroendocrinology; 2008 Feb; 33(2):152-61. PubMed ID: 18068306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.